Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 53: 1730-1733, 2007; 10.1373/clinchem.2007.093989
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bossuyt, X.
Right arrow Articles by Blanckaert, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bossuyt, X.
Right arrow Articles by Blanckaert, N.
Related Collections
Right arrow Laboratory Management
Right arrow Evidence Based Laboratory Medicine and Test Utilization
(Clinical Chemistry. 2007;53:1730-1733.)
© 2007 American Association for Clinical Chemistry, Inc.

Opinion

Laboratory Medicine: Challenges and Opportunities

Xavier Bossuyt1,a, Kurt Verweire2 and Norbert Blanckaert1

1 Laboratory Medicine, University Hospital Leuven, Leuven, Belgium
2 Vlerick Leuven Gent, Management School, Leuven, Belgium

aAddress correspondence this author at: Department of Laboratory Medicine, Immunology, University Hospital Leuven, Herestraat 49, B-3000 Leuven, Belgium. Fax 00-32-13-347042; e-mail xavier.bossuyt{at}uz.kuleuven.ac.be.

Technologic innovations have substantially improved the productivity of clinical laboratories, but the services provided by clinical laboratories are increasingly becoming commoditized. We reflect on how current developments may affect the future of laboratory medicine and how to deal with these changes. We argue that to be prepared for the future, clinical laboratories should enhance efficiency and reduce costs by forming alliances and networks; consolidating, integrating, or outsourcing; and more importantly, create additional value by providing knowledge services related to in vitro diagnostics.




The following articles in journals at HighWire Press have cited this article:


Home page
 J. Mol. Diagn.Home page
M. E. Gomah, J. P. Turley, H. Lu, and D. Jones
Modeling Complex Workflow in Molecular Diagnostics: Design Specifications of Laboratory Software for Support of Personalized Medicine
J. Mol. Diagn., January 1, 2010; 12(1): 51 - 57.
[Abstract] [Full Text] [PDF]

Home page
 Am J Clin PatholHome page
M. A. Proytcheva
Issues in Neonatal Cellular Analysis
Am J Clin Pathol, April 1, 2009; 131(4): 560 - 573.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Plebani
Laboratory Medicine: Value for Patients Is the Goal
Clin. Chem., October 1, 2007; 53(10): 1873 - 1874.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.